Analysts at Leerink Partnrs issued their FY2029 EPS estimates for shares of Merck & Co., Inc. in a research report issued to clients and investors on Friday, January 24th. Leerink Partnrs analyst D.
Intuitive Surgical (NASDAQ:ISRG – Free Report) had its target price boosted by JPMorgan Chase & Co. from $575.00 to $675.00 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback